Friday 12 December 2014

New Targeted Drugs Could Treat Drug-Resistant Skin Cancer

Clinical trials to test the new drugs in patients should begin as early as 2015. Existing drugs target faulty versions of a protein called BRAF which drives about half of all melanomas, but while initially very effective, the cancers almost always become resistant to treatment within a year. The new drugs - called panRAF inhibitors - could be effective in patients with melanoma who have developed resistance to BRAF inhibitors. The new study ...

via Medindia Health News More READ

No comments:

Post a Comment